5.70
+3.055(+115.50%)
Currency In USD
| Previous Close | 2.65 |
| Open | 6.46 |
| Day High | 8.27 |
| Day Low | 4.97 |
| 52-Week High | 48.6 |
| 52-Week Low | 2.2 |
| Volume | 103.7M |
| Average Volume | 512,232 |
| Market Cap | 5.72M |
| PE | -0.48 |
| EPS | -11.87 |
| Moving Average 50 Days | 3.09 |
| Moving Average 200 Days | 7.47 |
| Change | 3.06 |
If you invested $1000 in Longevity Health Holdings Inc. (XAGE) since IPO date, it would be worth $584.62 as of July 16, 2025 at a share price of $5.7. Whereas If you bought $1000 worth of Longevity Health Holdings Inc. (XAGE) shares 3 years ago, it would be worth $587.63 as of July 16, 2025 at a share price of $5.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
GlobeNewswire Inc.
Jul 14, 2025 8:30 PM GMT
PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced the execution of a definitive m
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
GlobeNewswire Inc.
May 27, 2025 1:20 PM GMT
Pittsburgh, PA, May 27, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we” or “our”), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnost
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
GlobeNewswire Inc.
May 21, 2025 8:30 PM GMT
PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”), a company focused on extending human longevity and healthy aging through innovative products in regenerative